Skip to main content
Article thumbnail
Location of Repository

Interferon-gamma coordinates CCL3-mediated neutrophil recruitment in vivo

By Cynthia A Bonville, Caroline M Percopo, Kimberly D Dyer, Jiliang Gao, Calman Prussin, Barbara Foster, Helene F Rosenberg and Joseph B Domachowske
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2662797
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2002). Abraham E: Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia.
    2. (2006). AM: Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection.
    3. (2005). An interferon-gamma related cytokine storm in SARS patients.
    4. (2004). BL: Interferon-γ activation of polymorphonuclear neutrophil function. Immunology
    5. (2003). Bronchoalveolar lavage fluids of ventilated patients with acute lung injury activate NF-kappaB in alveolar epithelial cell line: role of reactive oxygen/nitrogen species and cytokines. Nitric Oxide
    6. (2007). Chemokines and their receptors in respiratory disease: a therapeutic target for respiratory syncytial virus infection. Expert Rev Anti Infect Ther
    7. (2001). Cheng AF: Pathology of fatal human infection associated with avian influenza A H5N1 virus.
    8. (2008). Dakhama A: IFN-gamma production during initial infection determines the outcome of reinfection with respiratory syncytial virus. Am J Respir Crit Care Med
    9. (2005). der: Activation and inactivation of antiviral CD8 T cell responses during murine pneumovirus infection.
    10. (2006). Desmecht DJ: Differential resistance/susceptibility patterns to pneumovirus infection among inbred mouse strains.
    11. (2003). Domachowske JB: Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents.
    12. (2004). Domachowske JB: Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo.
    13. (2007). Domachowske JB: Immunization strategies for the prevention of pneumovirus infections. Expert Rev Vaccines
    14. (2008). Domachowske JB: Pneumonia virus of mice: severe respiratory infection in a natural host. Immunol Lett
    15. (2006). Domachowske JB: Respiratory dysfunction and proinflammatory chemokines in the pneumonia virus of mice (PVM) model of viral bronchiolitis. Virology
    16. (1999). Domachowske JB: Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. Am J Respir Crit Care Med
    17. (2005). Domachowske JB: The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention. Pharmacol Ther
    18. (2004). Durbin RK: Respiratory syncytial virus-induced immunoprotection and immunopathology. Viral Immunol
    19. (2003). E: Early alterations in neutrophil activation are associated with outcome in acute lung injury. Am J Respir Crit Care Med
    20. (2008). Ehl S: The role of T cells in virus control and disease after infection with pneumonia virus of mice.
    21. (1990). Finbloom DS: Characterization of the interaction between recombinant human interferon-γ and its receptor on human polymorphonuclear leukocytes.
    22. (2007). FP: Cytokine profiles in the respiratory tract during primary infection with human metapneumovirus, respiratory syncytial virus, or influenza virus in infants. Pediatrics
    23. (2007). GA: Severe respiratory syncytial virus bronchiolitis in infants is associated with reduced airway interferon gamma and substance P. PLoS ONE
    24. (2007). HF: Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice. Vaccine
    25. (2006). HF: Pneumonia virus of mice. Perspectives in Medical Virology
    26. (2000). HF: The chemokine macrophage-inflammatory protein-1alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection.
    27. (1951). Horsfall FL Jr: Characteristics of the multiplication cycle of pneumonia virus of mice (PVM).
    28. (1993). Immune response in mice that lack the interferon-gamma receptor. Science
    29. (1965). Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin. Science
    30. (2005). JE: Role for innate IFNs in determining respiratory syncytial virus immunopathology.
    31. (2001). Kimpen JL: Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity.
    32. (2005). Lim B: ARDS in SARS: cytokine mediators and treatment implications. Cytokine
    33. (2007). Migeotte I: F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affinity N-formylpeptide receptor.
    34. (2007). Mossmann TR: Human infant respiratory syncytial virus (RSV)
    35. (2006). Müller E: Acute respiratory distress syndrome and pneumonia: a comprehensive review of clinical data. Clin Infect Dis
    36. (1997). Newth CJ: Acute respiratory distress syndrome caused by respiratory syncytial virus. Pediatr Pulmonol
    37. (2005). PD: Inflammatory profile in nasal secretions of infants hospitalized with acute lower airway tract infections. Respirology
    38. (2005). Perng RP: Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome. J Chin Med Assoc
    39. (1997). PM: Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med
    40. (2004). PM: Mechanisms of host defense following severe acute respiratory syndromecoronavirus (SARS-CoV) pulmonary infection of mice.
    41. (1999). Popow-Kraupp T: Reduced interferongamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease. Am J Respir Crit Care Med
    42. Prussin C: Unit 6.24, Detection of intracellular cytokines by flow cytometry.
    43. (2005). RL: Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis
    44. (1999). S: Reduced interferon-gamma production in infants with bronchiolitis and asthma. Am J Respir Crit Care Med
    45. (1998). Silliman CC: Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release.
    46. (2001). Slegers H: Natural inhibitors of neutrophil function in acute respiratory distress syndrome. Crit Care Med
    47. (1995). Smithies O: Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science
    48. (1999). Sozzani S: Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-g in human neutrophils.
    49. (1993). TA: Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science
    50. (2000). Toews GB: The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection.
    51. (2007). Treatment with BX471, a nonpeptide CCR1 antagonist, protects mice against acute pancreatitisassociated lung injury by modifying neutrophil recruitment. Pancreas
    52. (2007). Tumpey TM, Katz JM: Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice.
    53. (2003). Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med
    54. (2006). W a n g H , D o n g C : Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. Am J Respir Crit Care Med
    55. (2006). Wu-Hsieh BA: Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro.
    56. (2006). YL: Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses. J Infect Dis

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.